Risk factors for alzheimer’s disease: A case-control study

Neuroepidemiology

Volumn 16, Issue 5, 1997, Pages 234-240

  Wang, Pei Ning ^a   Wang, Shuu Jiun ^a   Hong, Chen Jee ^b   Liu, Tsung Tun ^c   Fuh, Jong Ling ^a   Chi, Chin Wen ^c   Liu, Chia Yih ^d   Liu, Hsiu Chih ^a  

^a Neurological Institute   (Taiwan)

^b Department of Psychiatry ^*  (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Alzheimer rsquo; s disease; Apolipoprotein E; Risk factors; Smoking; Well water

Indexed keywords

APOLIPOPROTEIN E4; WELL WATER;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING; TAIWAN;

EID: 0030882167     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000109692     Document Type: Article

References (33)

1. Hofman A, Rocca WA, Brayne C, The European Risk Factors Group: Tiie prevalence of dementia in Europe: A collaborative study of 1980-1990 findings. IntJ Epidemiol 1991; 20:381-390.
2. Fratiglioni L, Grut M, Forsell Y, Viitamcn M, Grafstrom M, Holman K, Ericsson K. Backman L. Ahlbom A, Winblad B: Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: Relationship with age, sex, and education. Neurology 1991;45:86-96.
3. Ebly EM, Parhad IM, Hogan DE, Fung TS: Prevalence and types of dementia in the very old: Results from the Canadian Study of Health and Aging. Neurology 1994; 44:1593-1600.
4. Fratiglioni L: Epidemiology of Alzheimer’s disease: Issues of etiology and validity. Acta Neurol Scand Suppl 1993;145:1-70.
5. Van Duijn CM, Clayton D, Chandra V, The European Risk Factors Research Group: Familial aggregation of Alzheimer’s disease and related disorders: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S13-S21.
6. Silverman JM, Raiford K. Edland S, Fillenbaum G, Morris JC, Clark CM, Kukull W, Heyman A: The consortium to establish a registry for Alzheimer’s disease (CERAD). Part VI. Family history assessment: A multiccnter study of first-degree relatives of Alzheimer’s disease probands and nondemented spouse controls. Neurology 1994:44:1253-1259.
7. Van Duijn CM, Hofman A: Risk factors for Alzheimer’s disease: The EURODEM collaborative re-analysis of case-control studies. Neuro-epidemiology 1992;1 (suppl 1): 106-113.
8. Fratiglioni L: Epidemiology of Alzheimer’s disease and current possibilities for prevention. Acta Neurol Scand 1996;suppl 165:33-40.
9. Van Duijn CM: Epidemiology of the dementias: Recent developments and new approaches. J Neurol Neu-rosurg Psychiatry 1996:60:478-488.
10. Lee PN: Smoking and Alzheimer’s disease: A review of the epidemiological evidence. Ncurocpidcmiolo-gy 1994:13:131-144.
11. Graves AB, van Duijn CM, Chandra V, The European Risk Factors Research Group: Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl 2): S48-S57.
12. Brenner DE. Jujull WA. van Belle G. Bowen JD, McCormick WC, Tcri L. Larson EB: Relationship between cigarette smoking and Alzheimer’s disease in a population-based case-control study. Neurology 1993;43:293-300.
13. Breitcr JC. Gau BA. Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC: Inverse association of anti-inflammatory treatments and Alzheimer’s disease: Initial results of a co-twin control study. Neurology 1994:44:227-232.
14. Mckhann G. Drachman D. Folstein M. Katzman R. Price D. Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINADS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939-944.
15. Guo NW, Liu HC. Wong PF. Liao KK, Yan SH. Lin KP. Chang CY, Hsu TC: Chinese version and norms of the Mini-Mental State Examination. J Chin Rehabil Med 1988; 16: 52-56.
16. Teng EL, Hasegara K. Homma A. Imai Y. Larson E. Graves A: The cognitive abilities screening instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psychol 1994;6: 45-56.
17. Kaplan E. Goodglass H. Weintraub S: The Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
18. Sheikh JA, Yesavage JA: Geriatric depression scale (GDS): Recent findings and development of a shorter version. Clin Gerontologist 1986:5:165-173.
19. Hughe CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. BrJ Psychiatry 1982;140:566-572.
20. Blessed G, Tomlinson BE. Roth M: The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychol 1968;512:797-811.
21. Wenhan PR. Price WH, Blandcll G: Apolipoprotcin E genotyping by one-stage PCR. Lancet 1991;337: 1158-1159.
22. Hebert LE. Scherr PA. Beckett LA, Funkenstein HH, Albert MS, Chown CJ, Evans DA: Relation of smoking and alcohol consumption to incident Alzheimer’s disease. Am J Epidemiol 1992;135:347-355.
23. Van Duijn CM, Hofman A: Relation between nicotine intake and Alzheimer’s disease. BMJ 1991;302: 1491-1494.
24. Shalat SL, Seltzer B. Pidcock C, Baker EL: Risk factors for Alzheimer’s disease: A case-control study. Neurology 1987;37:1630-1633.
25. Kcllar KJ. Whitchousc PJ. Martino-Burrows AM, Marcus K. Price DL: Muscarinic and nicotinic cholinergic binding sites in Alzheimer’s disease cerebral cortex. Brain Res 1987;436:62-68.
26. JH]-nicotinc binding sites in human brain. J Neurochcm 1988;50; 1243-1247.
27. 3]nicotinic acetylcholine binding in Alzheimer’s disease and Parkinson’s disease: An autoradiographic study. Neurology 1988:38:720-723.
28. Sahakian B. Jones G, Levy R, Gray J, Warburton D: Effect of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer tvpc. Br J Psychiatry 1989; 154: 797-800.
29. Hart MN, Merz B, Bennett-Gray J, Mcnczcs AH. Gocken JA, Schelper RL, Wisniewski HM: p-Amyloid protein of Alzheimer’s disease is found in cerebral and spinal cord vascular malformations. Am J Pathol 1988;132:167-172.
30. Hong CJ, Liu TY. Liu HC. Wang SJ, Full SL, Chi CW. Leek Y. Sim CB: e4 allele of apolipoprotcin E increase risk of Alzheimer’s disease in a Chinese population. Neurology 1996:46:1749-1751.
31. Roses AD: Apolipoprotcin E genotyping in the differential diagnosis, not prediction of Alzheimer’s disease. Ann Neurol 1995;38:6-14.
32. Rajput AH. Uitti RJ, Stem W. Lav-erty W. O'Donnell K, O'Donnell D. Yuen WK, Dua A: Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson’s disease. Can J Neurol Sci 1987;14:414-418.
33. Jacqmin H. Commenges D, Laten-ncur L, Barberger-Gatcar P, Darti-gucs JF: Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol 1994;139:48-57.